•   
    Retina Subday 2019
    Macular Disease, Retina/Vitreous

    In this presentation from Retina Subday 2019, Dr. John Wells discusses the DRCR Retina Network's 5 year outcomes after aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.